What they were paid
Amphastar Pharmaceuticals Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $117,500 | $130,004 | $129,996 | $0 | $377,500 |
| FY2024 | $115,118 | $129,961 | $130,042 | $0 | $375,121 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Amphastar Pharmaceuticals, Inc. DEF 14A filed April 13, 2026, accession 0001297184-26-000023, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Amphastar Pharmaceuticals pays directors a $55,000 cash retainer and $260,000 in equity.
Committees
FY2025 · as the proxy prints themAudit · Compensation (Chair)
The rest of the Amphastar Pharmaceuticals board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| David Gaugh | Independent Director | $284,727 |
| Diane Gerst | Independent Director | $327,750 |
| Floyd F. Petersen | Independent Director | $325,000 |
| Gayle Deflin | Independent Director | $340,000 |
| Howard Lee | Independent Director | $333,500 |
| Jack Yongfeng Zhang | Director | $0 |
| Jacob Liawatidewi | Director | $0 |
| Mary Ziping Luo | Chair of the Board | $0 |
| Michael A. Zasloff | Independent Director | $331,000 |
| William J. Peters | Director | $0 |
The full Amphastar Pharmaceuticals compensation record
free company briefThis page is one director within Amphastar Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat